Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Colombo

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|May 17, 2011
Adalimumab for the treatment of immune-mediated diseases: an update on old and recent indicationsG Murdaca, B M Colombo, F Puppo
Il Farmaco; Edizione Pratica|June 1, 1972
Stability predictions for pharmaceutical preparationsB M Colombo, P Causa, P Primavera, et al.
Bollettino Chimico Farmaceutico|March 1, 1976
[Bioavailability and biopharmaceutics]B M Colombo, M M Colombo, R De Fusco
Allergy|July 1, 2008
Serum vascular endothelial growth factor and sublingual immunotherapyG Ciprandi, B M Colombo, G Murdaca, et al.
Cancer Research|April 6, 2001
Protection of mice against leukemia after vaccination with bone marrow-derived dendritic cells loaded with apoptotic leukemia cellsS Paczesny, S Beranger, J L Salzmann, et al.
Minerva Ginecologica|April 25, 2003
Peripartum cardiomyopathy. A reviewS Ferrero, B M Colombo, F Fenini, et al.
Biochemical and Biophysical Research Communications|October 31, 1991
Expression of the pp63 gene encoding the insulin receptor tyrosine kinase inhibitor in proliferating liver and in liver tumorsB M Colombo, L Falquerho, G Manenti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Low frequency of NF1 gene mutations in malignant gliomasM Tenan, B M Colombo, L Cajola, et al.
Cancer Genetics and Cytogenetics|June 1, 1994
p53 mutations and microsatellite analysis of loss of heterozygosity in malignant gliomasM Tenan, B M Colombo, B Pollo, et al.
Gene Therapy|February 4, 1999
In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapyN Cirenei, B M Colombo, M Mesnil, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Drugs of Today (Barcelona, Spain : 1998)|May 17, 2011
Adalimumab for the treatment of immune-mediated diseases: an update on old and recent indicationsG Murdaca, B M Colombo, F Puppo
Il Farmaco; Edizione Pratica|June 1, 1972
Stability predictions for pharmaceutical preparationsB M Colombo, P Causa, P Primavera, et al.
Bollettino Chimico Farmaceutico|March 1, 1976
[Bioavailability and biopharmaceutics]B M Colombo, M M Colombo, R De Fusco
Allergy|July 1, 2008
Serum vascular endothelial growth factor and sublingual immunotherapyG Ciprandi, B M Colombo, G Murdaca, et al.
Cancer Research|April 6, 2001
Protection of mice against leukemia after vaccination with bone marrow-derived dendritic cells loaded with apoptotic leukemia cellsS Paczesny, S Beranger, J L Salzmann, et al.
Minerva Ginecologica|April 25, 2003
Peripartum cardiomyopathy. A reviewS Ferrero, B M Colombo, F Fenini, et al.
Biochemical and Biophysical Research Communications|October 31, 1991
Expression of the pp63 gene encoding the insulin receptor tyrosine kinase inhibitor in proliferating liver and in liver tumorsB M Colombo, L Falquerho, G Manenti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Low frequency of NF1 gene mutations in malignant gliomasM Tenan, B M Colombo, L Cajola, et al.
Cancer Genetics and Cytogenetics|June 1, 1994
p53 mutations and microsatellite analysis of loss of heterozygosity in malignant gliomasM Tenan, B M Colombo, B Pollo, et al.
Gene Therapy|February 4, 1999
In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapyN Cirenei, B M Colombo, M Mesnil, et al.
Pageof 4